L1 - Intro to metabolism and metabolic control Flashcards

1
Q

Metabolism definition

A

Obtaining chemical energy by capturing solar energy or degrading energy-rich nutrients from the environment

Polymerize precursor molecules into macromolecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Catabolic pathways: what do they do, what do they produce, and what forms do they take?

A

Catabolic pathways break down energy containing macromolecules to produce chemical energy in the form of ATP, NADH, NADPH, and FADH2.

Degradation, releases energy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Anabolic pathways: what do they do, what do they produce, and what forms does it take?

A

Anabolic pathways use these energy carriers to convert small precursor molecules into cellular macromolecules (proteins, etc)

Biosynthesis, requires energy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Where does glycolysis occur?

A

Cytosol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Citric acid cycle

A

Mitochondria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Gluconeogenesis

A

Liver tissue - cytosol mainly (?)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Fatty acid synthesis

A

Mitochondria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

β-oxidation of fatty acids

A

Mitochondria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Triacylglycerol synthesis

A

ER

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Phospholipid synthesis

A

ER

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Amino acid synthesis

A

Cytoplasm/mitochondria

Occurs using intermediates gathered from the citric acid cycle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Amino acid degradation

A

Liver mainly (17/20) but also in:
* Kidney
* Skeletal muscle
* Muscle
* Adipose tissue
* Small intestines

Valine, leucine, and isoleucine occur in the tissues above as they are branched chain amino acids - cannot be transaminated in the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Oxidative phosphorylation/ATP synthesis

A

Glycolysis - cytosol

Aerobic respiration - inner mitochondria membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Glycogen synthesis and breakdown: in what tissues do they occur?

A

Synthesis - liver/muscle mainly
Breakdown - liver mainly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Protein synthesis

A

Extracellular - ribosomes on the ER
Intracellular - cellular 70s (?) ribosomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Lipoprotein synthesis

A

ER

17
Q

Which pathways involve several subcellular compartments?

A
  • Urea synthesis - mitochondria/cytosol
  • Release of glucose from glycogen - mitochondria/cytosol
  • Cholesterol synthesis - cytosol/endoplasmic reticulum
  • Long-chain fatty acids - cytoplasm (FAS2 type I) and in mitochondria (FAS type II)
18
Q

Maintaining overall metabolical balanced

A

Requires equal production and consumption of intermediates

v₁ v₂
A->S->P

A -
S -
P -
v - metabolic rate/flux

When v₁ and v₂ are equal, [S] is equal - homeostasis

19
Q

Reaction flux: what is it and what affects it?

A

Enzyme-catalyzed reaction rate

  • Number/concentration of enzyme molecules
  • -Catalytic activity of each enzyme molecule

Both can be modulated to increase or decrease the total activity of an enzyme

20
Q

The 10 key factors that affect enzyme activity

A

1–5 - change the number of molecules of the enzyme:
* Extracellular signals
* Transcription of specific genes
* mRNA degradation
* mRNA translation of ribosome
* Protein degradation

6 – movement of the enzyme between subcellar compartments

7–10 change the catalytic activity of the enzyme:
* Enzyme-substrate binding
* Allosteric activation/inhibition
* (de)Phosphorylation
* Regulatory protein binding

21
Q

Extracellular signals: what is an example and what can they do?

A

Hormones - carried in the bloodstream from endocrine gland (e.g. pancreas) to target cells or organs (e.g. liver)

Bring about changes in target cell, change in transcription of genes encoding metabolic enzymes or may cause altered activity of existing enzyme

22
Q

Transcription of specific genes

A

May be influenced by intra or extracellular signals

23
Q

mRNA degradation

A

mRNA degradation - should result in less production

24
Q

mRNA translation of ribosome

A

mRNA translation - should result in increased production

25
Q

Protein degradation

A

Once synthesised, protein molecules have finite lifetime, the rate of degradation differs from one enzyme to another

Liver enzymes: <1 hour - > 1 week

Degradation can be regulated to alter enzyme concentration

Example: HMG-CoA reductase (cholesterol biosynthesis)

26
Q

Movement of the enzyme between subcellar compartments

A

Movement of metabolites between compartments can also be a point of regulation

Example - Glucokinase regulatory protein sequesters hexokinase IV (glucokinase) in the nucleus (ePBL)

27
Q

Enzyme-substrate binding: how does substrate concentration affect the rate, what is kₘ, when does kₘ reaction rate depend on the substrate concentration, and what is the typical enzyme kₘ?

A

The rate is more sensitive to increase due to substrate concentration at low concentrations - the frequency of substrate meeting the enzyme is limiting

The rate becomes insensitive at high substrate concentrations - the enzyme is nearly saturated with substrate

kₘ - the concentration of substrate that allows the enzyme to achieve half vₘₐₓ

  • When [substrate] < Km
  • If Km is greater than physiological [substrate], changes in [substrate] will alter reaction rate

Many enzymes have Km near or greater than the physiological [substrate], meaning that changes in [substrate] will cause changes in reaction rate

28
Q

Allosteric activation/inhibition: what are the molecules that cause allosteric effects, do they activate or inhibit, and how do they do their function?

A

Allosteric effectors or modulators are generally small molecules - often metabolites, intermediates, or end-products of a pathway

Allosteric effectors can be activators or inhibitors

Bind non-covalently to a specific regulatory site that is different to the active site

29
Q

(de)phosphorylation: what are they caused by, what specific components of substances are affected, and what is their effect?

A
  • Phosphorylation is catalysed by protein kinases
  • Dephosphorylation is catalyzed by protein phosphatases (can be spontaneous)

Specific amino acids are phosphorylated

The phosphate group alters properties e.g. structure leading to change in activity

30
Q

Regulatory protein binding: what is it and what is the example?

A

The binding of regulatory protein subunits can affect the specificity

E.g. phosphoprotein phosphatase 2A (PP2A)
* Recognizes several substrate proteins
* Specificity is determined by regulatory subunit
*Creates unique substrate binding site - conferring specificity

31
Q

Compartmentalisation: why is it useful?

A

Anabolic/catabolic pathways of substances can be separated and regulated without interfering with one another

32
Q

How much of the genome is regulatory?

A

Thought to be up to 10%!

This is because the importance of keeping homeostasis